首页> 外文期刊>Therapeutic advances in endocrinology and metabolism. >Association between the risk of death and serum calcium, phosphate, and intact parathyroid hormone levels in older patients undergoing maintenance hemodialysis: a cohort study in Beijing
【24h】

Association between the risk of death and serum calcium, phosphate, and intact parathyroid hormone levels in older patients undergoing maintenance hemodialysis: a cohort study in Beijing

机译:在进行维持血液透析的老年患者中死亡和血清钙,磷酸盐和完整甲状旁腺激素水平之间的关联:北京的队列研究

获取原文
           

摘要

Background: The number of patients ?65?years who require maintenance hemodialysis (MHD) is increasing. Although reduced bone turnover in older patients receiving hemodialysis, as reflected by lower serum intact parathyroid hormone (iPTH) and phosphate (P) levels, has been reported, focus on the association between abnormal bone metabolism and the risk of death in older patients receiving MHD has been limited. Methods: We retrospectively examined data from the Beijing Hemodialysis Quality Control and Improvement Center for 1410 older patients who underwent hemodialysis from 1 January 2012 to 31 December 2016. Baseline, time-dependent (TD) Cox proportional hazards models and Kaplan–Meier analyses were used to evaluate the association between the markers of mineral and bone disorder (MBD) [calcium (Ca), P, and iPTH] and survival. The Kidney Disease: Improving Global Outcomes (KDIGO) target ranges were included as reference values. Results: Serum P levels 2.49?mmol/l increased the risk of all-cause death [hazard ratio (HR): 1.46; 95% confidence interval (CI): 1.04–2.07; p?=?0.030] and cardiovascular death (HR: 2.01; 95%CI: 1.21–3.34; p?=?0.007); iPTH levels 600?pg/ml increased the risk of cardiovascular death (HR: 1.95; 95%CI: 1.20–3.15; p?=?0.007). Baseline results and TD Cox analyses were similar. All three MBD parameters were within the respective target ranges at least once during the follow-up period in 399 (28.3%) patients, and these patients had better survival rates than those who achieved two of the three target ranges (715/1410 patients; 50.7%); those who achieved one or no target range (296/1410; 21.0%) had the lowest survival rate (all-cause death: log-rank chi square?=?83.96, p??0.001; cardiovascular death: log-rank chi square?=?47.06, p??0.001). Conclusion: Older patients undergoing MHD who achieved the KDIGO target levels for any two or three MBD parameters had lower risks of all-cause and cardiovascular death.
机译:背景:患者的数量?65?需要维持血液透析(MHD)的岁月正在增加。据报道,虽然接受血液透析的老年患者的骨质周转减少,但由于患有较低的血清完整的甲状旁腺激素(IPTH)和磷酸盐(P)水平反映,重点关注异常骨代谢与接受MHD的老年患者死亡风险已经有限。方法:从2012年1月1日至2016年12月31日,我们回顾性地检查了北京血液透析质量控制和改善中心的数据。评价矿物质和骨紊乱(MBD)[钙(CA),P和IPTH]和存活率之间的关联。肾脏疾病:改善全球结果(KDIGO)目标范围作为参考值。结果:血清P水平& 2.49?MMOL / L增加了全因死亡的风险[危险比(HR):1.46; 95%置信区间(CI):1.04-2.07; P?= 0.030]和心血管死亡(HR:2.01; 95%CI:1.21-3.34; P?= 0.007); IPTH水平& 600?pg / ml增加了心血管死亡的风险(HR:1.95; 95%CI:1.20-3.15; p?= 0.007)。基线结果和TD COX分析是相似的。所有三个MBD参数在399(28.3%)患者的后续期间至少一次的各个目标范围内,这些患者的生存率比达到三个目标范围中的两种患者(715/1410名患者; 50.7%);获得一个或没有目标范围的人(296/1410; 21.0%)的存活率最低(全因死死亡:对数秩Chi Square?=?83.96,P?& 0.001;心血管死亡:日志排名Chi Square?=?47.06,p?<0.001)。结论:接受MHD的老年患者达到任何两种或三个MBD参数的KDIGO目标水平,具有较低的全因和心血管死亡风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号